Eversept Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Eversept Partners's ROIV Position: Q3 2026 in Review
Eversept Partners opened a new position in Roivant Sciences (ROIV) in Q3 2026: 419,138 shares worth $15.3M. The stake represents 0.82% of the portfolio and ranks #34 among its holdings.
522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Eversept Partners held 419,138 shares of Roivant Sciences worth $15.3M as of Q3 2026.
- Roivant Sciences was a new Eversept Partners position in Q3 2026.
- Roivant Sciences made up 0.82% of Eversept Partners's portfolio in Q3 2026, its #34 holding.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.